Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo…

Overview of attention for article published in Journal of Gastroenterology, August 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 9,310 followers.

エロビキシバット https://t.co/7isIp9a011 https://t.co/eeF2BYfgG5 ポリエチレングリコール https://t.co/zVJ2utw369 https://t.co/VSL5XU8oNu

13 Jan 2020

Reply Repost Favourite

RT @syuichiao89: Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese pati…

16 Mar 2018

Reply Repost Favourite

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.　https://t.co/eeF2

16 Mar 2018

Reply Repost Favourite